Borrelli, O <br/><br/>
Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.  [electronic resource] 

 -  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver  May 2004 
 - 342-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1590-8658 
<br/><br/><label>Standard No.: </label>10.1016/j.dld.2003.12.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Monoclonal--therapeutic use<br/>Azathioprine--therapeutic use<br/>Blood Sedimentation<br/>Body Height--physiology<br/>Body Weight--physiology<br/>C-Reactive Protein--analysis<br/>Child<br/>Crohn Disease--drug therapy<br/>Drug Administration Schedule<br/>Gastrointestinal Agents--therapeutic use<br/>Hemoglobins--analysis<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Infliximab<br/>Infusions, Intravenous<br/>Prospective Studies<br/>Remission Induction--methods<br/>Serum Albumin--analysis